FDA Inspection
Sumitomo Dainippon Pharma Co., Ltd.Sumitomo Dainippon Pharma Co., Ltd. – FDA Inspection, Nov 22, 2019
Record Details
This FDA Inspection record concerns Sumitomo Dainippon Pharma Co., Ltd., with an inspection on November 22, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 22, 2019
- Product Type
- Drugs
View Company Profile
ID · 1c86b0d4-989e-4cae-ad7f-4339b52c4cd9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1113228
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Sumitomo Dainippon Pharma Co., Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 7, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| July 27, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 9, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 1, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sumitomo Dainippon Pharma Co., Ltd.
- FDA Inspection 1277764 - 2025-08-07
- FDA Inspection 1064584 - 2018-07-27
- FDA Inspection 990466 - 2016-09-09
- FDA Inspection 853865 - 2013-11-01
- FDA Inspection 770009 - 2012-02-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.